(MedPage Today) – Sarepta Therapeutics said on Sunday: Sarepta Therapeutics said on Sunday: Sarepta Therapeutics said on Sunday that the patient with muscle atrophy in a second Duchene died after his treatment with Delandistrogene Moxeparvovec (Elevidys). Like the first case reported, this acute patient has developed …
